Explore the full insider trade history of 에스엘에스바이오, a publicly traded company based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Healthcare sector, 에스엘에스바이오 has recorded 1 public disclosures. Market capitalisation: €29.6bn. The latest transaction was disclosed on 10 March 2026 (Other). Among the most active insiders: 에스엘에스바이오. Every trade is free.